跳到正文
原文
Endpoints News 生物医药· ENDPOINTS·· 18 天前AI 评分26

uniQure 获 FDA 审评日期与咨询委员会审核;Inovio 股价上涨

UniQure gets review date and adcomm; Inovio's stock surges after approval

AI 导读

FDA 给予 uniQure 一个审评日期并安排咨询委员会审核,Inovio 股价因获批消息上涨。

正文

Plus news about Ab­b­Vie, Gilead and Tiziana Life Sci­ences.

FDA gives uniQure a re­view date and ad­comm: The agency will de­cide whether or not to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news